MANDAMUS (¥€$)
Welcome to Mandamus
Mandamus (¥€$) is a research and Development Token (ERC-20) powering the R&D of blockchain technology and decentralization applications across industries.
Buy Mandamus
View Whitepaper

Pick a Wallet

Picture

Ledger Hardware Wallet

Click Here to Buy
Picture

Download Metamask

Install Metamask on iPhone/iPad
Install Metamask on Android
Picture
Picture

Worldwide Integration of Blockchain Technology

Mandamus R&D projects enable better integration of blockchain technology into daily life, From tourist locations to the local daily mom and dad store. Pilot Programs will start in Puerto Rico, Continental USA and Dominican Republic and expand to every continent globally.
Learn More

The Community Votes and we Research and Develop

​Members of the crypto community will vote on different projects, and the platform will research and develop the project; after lunch, we will provide a fully open-source report on ways other crypto projects with other coins can integrate it into their blockchain and/or ecosystem.

Reserve Funds

Ten (10) Percent of All net revenue will be held in a reserve account in the United States of America. Reserve Account will be tied to the Mandamus Coin, and funds will be held in U.S. Dollars, Gold, and short-term U.S. government obligations. The Higher the value of the Mandamus Token and the more transactions made with the token, the higher the number of backed funds in the reserve account.
Learn More

Picture

Add liquidity on UNISwap

Picture
Enter
Picture

Mandamus R&D Platform

Picture
Coming Soon
Picture

View Mandamus Contract

Picture
ENTER

Mandamus Coin grows so does the charity contributions

Pay for treatment for infants with spinal muscular atrophy (SMA) type 1

Part of the generated revenue and growth of the Mandamus token will be used to pay for the treatment of infants with SMA. ZOLGENSMA is a prescription gene therapy used to treat children less than 2 years old with spinal muscular atrophy (SMA). ZOLGENSMA is given as a one-time infusion into a vein. Most of the Infants with SMA type 1 treated with Zolgensma survive after treatment. Zolgensma is one of the most expensive medicine in the world and with our support we can help infants if their insurance doesn't cover the full or partial treatment cost.
Learn More

What is Spinal Muscular Atrophy Type 1?

Spinal muscular atrophy (SMA) is a genetic (inherited) neuromuscular disease that causes muscles to become weak and waste away. People with SMA lose a specific type of nerve cell in the spinal cord (called motor neurons) that control muscle movement. Without these motor neurons, muscles don’t receive nerve signals that make muscles move. The word atrophy is a medical term that means smaller. With SMA, certain muscles become smaller and weaker due to lack of use. 
​
Type 1 (severe): About 60% of people with SMA have type 1 , also called Werdnig-Hoffman disease. Symptoms appear at birth or within an infant’s first six months of life. Infants with type 1 SMA have difficulty swallowing and sucking. They don’t meet typical milestones like holding up their heads or sitting. As muscles continue to weaken, children become more prone to respiratory infections and collapsed lungs(pneumothorax). Most children with type 1 SMA die before their second birthday.
Learn More

Join our Waiting list!

We are currently developing the Platform. Fill out the form to get updates on our stages of development. You can still buy the Mandamus token via UNISwap and Tokpie Exchange
Submit
Picture

Mandamus Verified Address

​0xc5a7EbEdce820F06a610289370c2430596E81fa8

Mandamus Coin

About Us
WhitePaper
Forex Mandamus Services Inc
Etherscan
Github
OpenSea
Contact Us

Follow us on social media

Picture
Picture
Picture
Picture

Linkedin Profiles:

Mandamus Coin

Founding Members

Forex Mandamus Services Inc
Jose Miranda Ramos

Support the platform and Donate ETH or any other ERC-20 Token to:

0xd3490E6A3c70FDa0f8209F07c5574BbF52Fd42Fb
or donate via coinbase commerce
Donate with Crypto

© COPYRIGHT 2015 - 2022 Forex Mandamus Services Inc. ALL RIGHTS RESERVED.
DMCA.com Protection Status
  • Home
  • About Us
  • White Paper
  • View On EtherScan
  • Contact US
  • Home
  • About Us
  • White Paper
  • View On EtherScan
  • Contact US